Komori

COSMOS Pharmaceutical Corporation

3349RetailLarge cap
6,323JPY+2.8%
★ Watch (sign-up required)
Price history
¥6,323Latest-28.2%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview

COSMOS Pharmaceutical Corporation operates drugstores across Japan selling everyday essential consumables, including pharmaceuticals, cosmetics, sundries and general food products. It operates stores in the Kanto, Chubu, Kansai, Chugoku, Shikoku and Kyushu regions, with a total of 1,708 stores, through a group structure comprising グリーンフラッシュ and its consolidated subsidiaries. グリーンフラッシュ is responsible for comprehensive store maintenance and management and is certified as a special subsidiary for the employment of people with disabilities. Its main product categories include pharmaceuticals, cosmetics, sundries, gardening supplies, automotive products, clothing, general food products and other items.

Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
Loading
Documents
See all timely disclosuresSee all statutory filings
News
See all news
Key numbersShowing 8 of 20
PER
16.33How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.
PBR
1.85How many times the company's net assets? Around 1x is generally considered a benchmark.
ROE
11.3%Earning power. A figure above 10% is generally considered good.
Dividend yield
0.0%The annual dividend as a percentage of the share price.
Market capitalization
¥523bnShare price × number of shares. The value of the entire company.
Equity ratio
47.6%The proportion of assets funded by money that does not have to be repaid.
Operating margin
3.9%The percentage of revenue remaining from the company’s core business.
Revenue growth (3 years)
9.9%The average annual growth in sales over the past three years.
What to watch next
Same-store sales growth year on year and post-opening ramp-up, including new-store sales and investment payback
Upcoming quarterly results through 2027Impact HighLikelihood Medium
Specific progress on store openings and investment related to expansion into Tohoku, which is finally planned for the next fiscal year, together with initial profitability
Execution phase of the 2025–2026 plan, with updates in results and disclosuresImpact MediumLikelihood Medium
Notifications of new store establishments and openings by ドラッグコスモス, including multiple new stores reportedly scheduled for January–February 2027
January–February 2027Impact MediumLikelihood High
Emergence of risks from procedural or review delays under the Pharmaceuticals and Medical Devices Act and the Large-Scale Retail Store Location Act, with potential knock-on effects on the pace of store openings
As each store-opening plan arises, throughout the yearImpact MediumLikelihood Medium
What to watch next
Loading
Who owns itTop holders total 67.8%
Listed holders 67.8%Everyone else 32.2%
有限会社萬緑38.65%
The Master Trust Bank of Japan, Ltd. (Trust Account)7.93%
株式会社日本カストディ銀行 (Trust Account)4.13%
公益財団法人余慶会3.79%
管理信託（A036）3.03%
管理信託（A037）2.59%
管理信託（A038）2.59%
コスモス薬品従業員持株会1.98%
2 other listed holders3.07%
Who owns it
HolderOwnership (%)
有限会社萬緑38.65
The Master Trust Bank of Japan, Ltd. (Trust Account)7.93
株式会社日本カストディ銀行 (Trust Account)4.13
公益財団法人余慶会3.79
管理信託（A036）3.03
管理信託（A037）2.59
管理信託（A038）2.59
コスモス薬品従業員持株会1.98
2 other listed holders3.07
This company's documents
Filings
Timely disclosures
Threads